Cooperative Agreement NU51IP000915

Award Date 9/30/21
Completion Date 9/29/26
Dollars Obligated $1.6M
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.318
Assistance Type
Cooperative Agreement
Place of Performance
Togo
Similar Awards
This federal Cooperative Agreement award of $6,402,000.00 from the Centers for Disease Control and Prevention's (CDC) Investigations and Technical Assistance program (CFDA 93.283) is supporting the "REINFORCING IMMUNIZATION SYSTEMS FOR CONSEQUENTIAL GEOGRAPHIES(RISE4CGS)IN DRC, ETHIOPIA AND NIGERIA" project implemented by the African Field Epidemiology Network LTD (AFENET), a non-profit organization based in Uganda. The 5-year project, awarded on September 30, 2024, aims to...
This $6,000,000 Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security program (CFDA 93.318), supports comprehensive global health security and capacity building initiatives by the National Health Laboratory Service (NHLS) in South Africa. Key activities funded under this 5-year award include: strengthening infectious disease...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 "CDC Investigations and Technical Assistance" program provides $1,729,736 to the District of Columbia Department of Health (DC Health) to support epidemiology and laboratory capacity for prevention and control of emerging infectious diseases. The key products and services to be delivered under this 5-year award include: Enhancing DC Health's epidemiologic surveillance...
This federal Project Grant award of $246,521, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a workforce development program to train public health and clinical research professionals in West Africa. The key products and services delivered through this grant include: Establishing a training program at the University of Sciences, Techniques and Technologies of Bamako (USTTB) in Mali...
The Louisiana Department of Health, doing business as the Office of Public Health (OPH), was awarded a 5-year Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program. The $1,296,395 award, effective August 1, 2024, will support Louisiana's epidemiology and laboratory capacity for infectious disease prevention and response across several key projects, including: A. Crosscutting Epidemiology and...
The Task Force for Global Health, Inc. was awarded a $2,475,519 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The five-year award, effective from August 1, 2024 to July 31, 2029, supports the organization's efforts to strengthen public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases globally. Key activities...
This federal Cooperative Agreement award, valued at $567,612.00 and awarded by the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421), supports efforts to enhance infectious disease epidemiology, laboratory, and entomology capacity for the Mississippi State Department of Health (MSDH). The key objectives are to maintain a proficient public health...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve the quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives include scaling up quality assurance and improvement for HIV rapid testing and other diagnostic services, implementing quality management systems in diagnostic...
This Cooperative Agreement award, totaling $15,754,880.00 and spanning Sep 30, 2024 to Sep 29, 2029, is funded by the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283). The primary awardee, the Ministry of Health Central Public Health Laboratories (CPHL) in Uganda, will use the funding to strengthen national health laboratory services and partnerships in Uganda for quality HIV-related testing and other diagnostics. Key activities...
This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

MAINTAIN CAPACITY FOR ROUTINE SURVEILLANCE OF INFLUENZA TO DETECT AND RESPOND TO PANDEMIC INFLUENZA AND SUPPORT CAPACITY DEVELOPMENT FOR RESPONDING TO OTHER RESPIRATORY INFECTIOUS DISEASE OUTBREAKS. - PROJECT ABSTRACT SUMMARYFUNDING OPPORTUNITY TITLE: SURVEILLANCE AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA BY NATIONAL HEALTH AUTHORITIES OUTSIDE THE UNITED STATESAGENCY FUNDING OPPORTUNITY NUMBER ? CDC-RFA-IP21-2101SUBMITTED BY: INSTITUT NATIONAL D?HYGIENE, NATIONAL PUBLIC HEALTH LABORATORY, LOME-TOGO PROJECT TITLE: MAINTAIN CAPACITY FOR ROUTINE SURVEILLANCE OF INFLUENZA TO DETECT AND RESPOND TO PANDEMIC INFLUENZA AND SUPPORT CAPACITY DEVELOPMENT FOR RESPONDING TO OTHER RESPIRATORY INFECTIOUS DISEASE OUTBREAKS. THE PURPOSE OF THE REQUEST: THE PURPOSE OF THE APPLICATION IS TO SEEK GRANTS TO MAINTAIN CAPACITY FOR ROUTINE SURVEILLANCE OF INFLUENZA TO DETECT AND RESPOND TO PANDEMIC INFLUENZA AND SUPPORT CAPACITY DEVELOPMENT FOR RESPONDING TO OTHER RESPIRATORY INFECTIOUS DISEASE OUTBREAKS. THE PERIOD OF THE PROJECT: THE TOTAL PERIOD OF THE PROJECT IS 5 YEARS FROM 2021 TO 2026. THE AMOUNT NEEDED: THE AMOUNT NEED TO ACHIEVE THE OBJECTIVES OF THIS PROJECT IS TWO MILLION THREE HUNDRED SIXTY ONE THOUSAND THREE HUNDRED SIXTY EIGHT U.S DOLLARS (2,361,368 US$)PROJECT MEASUREMENTS AND EVALUATION COMPONENT 1: BASIC INFLUENZA ACTIVITIESOBJECTIVE 1.1: BUILD AND MAINTAIN AN INFORMATION MANAGEMENT SYSTEM FOR SURVEILLANCE DATA?MEASURABLE RESULT 1.1.1: THE MONITORING OF THE QUALITY, ACCURACY, COMPLETENESS AND PROMPTNESS IN THE TRANSMISSION OF EPIDEMIOLOGICAL AND VIROLOGICAL DATA IS PERFOMED. ?MEASURABLE RESULT 1.1.2: COORDINATION AND COMMUNICATION ON A MONTHLY BASIS BETWEEN THE MINISTRY OF HEALTH AND THE MINISTRY OF AGRICULTURE IS STRENGTHENED OBJECTIVE 1.2: IMPROVE THE SUSTAINABILITY OF THE NATIONAL INFLUENZA SURVEILLANCE SYSTEM ?MEASURABLE RESULT 1.2.1: THE DEVELOPMENT PLAN FOR THE NATIONAL INFLUENZA SURVEILLANCE SYSTEM IS UPDATED. ? MEASURABLE RESULT 1.2.2: RESEARCH AXES ON INFLUENZA AND OTHER DISEASES ARE DEVELOPED?MEASURABLE RESULT 1.2.3: SCIENTIFIC ARTICLES PRODUCED AND PUBLISHEDOBJECTIVE 2.1: STRENGTHEN THE SENTINEL SURVEILLANCE SYSTEM OF SARI AND ILI?MEA SURABLE RESULT 2.1.1: NEW SARI/ILI SENTINEL SITES OF INFLUENZA IN THE KARA REGION ARE ESTABLISHED.?MEASURABLE RESULT 2.1.2: THE SKILLS OF ALL SURVEILLANCE STAFFS ARE STRENGTHENED.?MEASURABLE RESULT 2.1.3: MAINTAIN THE COLLECTION OF 2000 SAMPLES PER YEAR FROM SARI AND ILI PATIENTS. ?MEASURABLE RESULT 2.1.4: REGULAR COLLECTION OF INFLUENZA DATA IN PATIENTS WITH SARI AND ILI.?MEASURABLE RESULT 2.1.5: SUPERVISION OF INFLUENZA SURVEILLANCE ACTIVITIES IS CARRIED OUT IN SENTINEL SITES.?MEASURABLE RESULT 2.1.6: THE INFLUENZA SENTINEL SITES ACTIVITIES ARE REVIEWEDOBJECTIVE 2.2: STRENGTHEN THE SURVEILLANCE OF OUTBREAKS OF SEVERE AND FEBRILE RESPIRATORY ILLNESSES?MEASURABLE RESULT 2.2.1: SETTING UP OF AN EARLY ALERT SYSTEM THAT PROMPTLY REPORT SUSPECTED CASES OR CLUSTERS OF SEVERE RESPIRATORY AND FEBRILE ILLNESSES TO NATIONAL AUTHORITIES AND WHO AND PROVIDING APPROPRIATE SAMPLES FOR TESTING IN A TIMELY MANNER. ?MEASURABLE RESULT 2.2.2: IMPROVEMENT OF THE AWARENESS OF HUMAN AND ANIMAL HEALTH PROFESSIONALS AND WORKER COMMUNITIES ON HOW TO IDENTIFY AND REPORT UNUSUAL CASES OR CLUSTERS OF RESPIRATORY DISEASES IN HUMANS OR ANIMALS. OBJECTIVE 2.3: STRENGTHEN THE PREPARATION AND COMMUNICATION OF NATIONAL REPORTS ON SYSTEMATIC SURVEILLANCE OF INFLUENZA?MEASURABLE RESULT 2.3.1: CARRYING OUT OF A STANDARD MONTHLY INFLUENZA REPORT (SMR) AND SHARING WITH SENTINEL SITES, THE MINISTRY OF HEALTH, PARTNERS IN THE COUNTRY AND WHO. ?MEASURABLE RESULT 2.3.2: SHARING OF EPIDEMIOLOGICAL AND VIROLOGICAL DATA PER WEEK THROUGH THE WHO TOOLS FLUID AND FLUNET IS MAINTAINED. ?MEASURABLE RESULT 2.3.3: AN ANNUAL INFLUENZA REPORT WITH MOH, COUNTRY PARTNERS IS PRODUCED ANNUALLY AND SHARED WITH PARTNERS INCLUDING SENTINEL SITES, CDC, WHO, ETC.?...OBJECTIVE 3.1: STRENGTHEN THE CAPACITY OF THE NATIONAL INFLUENZA LABORATORY?MEASURABL

Posted 8/4/21, 12:00 AM